JPWO2023120643A5 - - Google Patents
Info
- Publication number
- JPWO2023120643A5 JPWO2023120643A5 JP2023569535A JP2023569535A JPWO2023120643A5 JP WO2023120643 A5 JPWO2023120643 A5 JP WO2023120643A5 JP 2023569535 A JP2023569535 A JP 2023569535A JP 2023569535 A JP2023569535 A JP 2023569535A JP WO2023120643 A5 JPWO2023120643 A5 JP WO2023120643A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- cxcr3 ligand
- native human
- cxcl10
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021209975 | 2021-12-23 | ||
| PCT/JP2022/047366 WO2023120643A1 (ja) | 2021-12-23 | 2022-12-22 | Cxcr3発現細胞遊走活性が増強したcxcr3リガンド。 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023120643A1 JPWO2023120643A1 (cg-RX-API-DMAC7.html) | 2023-06-29 |
| JPWO2023120643A5 true JPWO2023120643A5 (cg-RX-API-DMAC7.html) | 2025-11-28 |
Family
ID=86902738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023569535A Pending JPWO2023120643A1 (cg-RX-API-DMAC7.html) | 2021-12-23 | 2022-12-22 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250073307A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4455158A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2023120643A1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN118660904A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023120643A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3892330A4 (en) | 2018-12-04 | 2022-10-26 | Chugai Seiyaku Kabushiki Kaisha | CXCR3 LIGAND |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003082335A1 (fr) * | 2002-04-03 | 2003-10-09 | Sumitomo Pharmaceuticals Co., Ltd. | Nouveau dispositif de controle du sucre dans le sang et procede de criblage associe |
| US20090131312A1 (en) * | 2005-05-18 | 2009-05-21 | Lawrence Blatt | Non-natural chemokine receptor ligands and methods of use thereof |
| AU2017364818C1 (en) | 2016-11-28 | 2025-05-15 | Chugai Seiyaku Kabushiki Kaisha | Ligand-binding molecule having adjustable ligand binding activity |
| KR20200089312A (ko) | 2017-11-28 | 2020-07-24 | 추가이 세이야쿠 가부시키가이샤 | 리간드 결합 활성을 조정 가능한 리간드 결합 분자 |
| KR20250134208A (ko) | 2017-11-28 | 2025-09-09 | 추가이 세이야쿠 가부시키가이샤 | 항원 결합 도메인 및 운반 부분을 포함하는 폴리펩티드 |
| EP3892330A4 (en) * | 2018-12-04 | 2022-10-26 | Chugai Seiyaku Kabushiki Kaisha | CXCR3 LIGAND |
| WO2021038033A1 (en) | 2019-08-29 | 2021-03-04 | Antagonis Biotherapeutics Gmbh | T-cell mobilizing cxcl10 mutant with increased glycosaminoglycan binding affinity |
-
2022
- 2022-12-22 WO PCT/JP2022/047366 patent/WO2023120643A1/ja not_active Ceased
- 2022-12-22 EP EP22911345.1A patent/EP4455158A4/en active Pending
- 2022-12-22 CN CN202280091299.9A patent/CN118660904A/zh active Pending
- 2022-12-22 JP JP2023569535A patent/JPWO2023120643A1/ja active Pending
- 2022-12-22 US US18/722,266 patent/US20250073307A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Persson et al. | Purification and biochemical characterization of CP4 (SP-D), a collagenous surfactant-associated protein | |
| Holmes et al. | The protein phosphatases involved in cellular regulation: Primary structure of inhibitor‐2 from rabbit skeletal muscle | |
| Tang | Specificity of pepsin and its dependence on a possible ‘hydrophobic binding site’ | |
| McCormick et al. | Hemoglobin binding with haptoglobin: delineation of the haptoglobin binding site on the α-chain of human hemoglobin | |
| Tanaka et al. | Immunological identification of the major disulfide-linked light component of silk fibroin | |
| Huisman et al. | The structure of goat hemoglobins: i. Structural studies of the β chains of the hemoglobins of normal and anemic goats | |
| KR890006668A (ko) | 폴리펩티드 | |
| JP2023518596A5 (cg-RX-API-DMAC7.html) | ||
| JPH11506739A (ja) | 脂肪酸アシル化蛋白質のゲル化削減法 | |
| JP2008073057A (ja) | 複数のctp付加を有するホルモンアナログ | |
| JP2007505643A5 (cg-RX-API-DMAC7.html) | ||
| JPH0547524B2 (cg-RX-API-DMAC7.html) | ||
| JP2004525608A5 (cg-RX-API-DMAC7.html) | ||
| Geisow et al. | Large fragments of human serum albumin | |
| Fik et al. | Comparative biochemical analysis of lectin and nuclease from Chelidonium majus L. | |
| RU2018128613A (ru) | Мутированный фактор фон виллебранда | |
| JPWO2020116498A5 (cg-RX-API-DMAC7.html) | ||
| Shimomura et al. | Rapid purification and characterization of human platelet glycoprotein V: the amino acid sequence contains leucine-rich repetitive modules as in glycoprotein Ib | |
| Kuo et al. | Orientation of type VI collagen monomers in molecular aggregates | |
| Moore Jr | Purification and partial characterization of epidermal growth factor isolated from the male rat submaxillary gland | |
| Koshland et al. | Differences in amino acid composition related to allotypic and antibody specificity of rabbit IgG heavy chains | |
| Adlersberg et al. | Repetitive hinge region sequences in human IgG3: isolation of an 11,000-dalton fragment. | |
| JP2007501224A (ja) | 安定剤としての組換え又は合成ゼラチン様タンパク質の、凍結乾燥医薬組成物中の使用 | |
| SAITOH et al. | Further Fractionation of Basic Proline-Rich Peptides from Human Parotid Saliva and Complete Amino Acid Sequence of Basic Prolme-Rich Peptide PH | |
| Fawell et al. | Androgen-regulated proteins of rat seminal vesicle secretion constitute a structurally related family present in the copulatory plug |